Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Journal article
Rosenkranz M. et al, (2024), Life Sci Alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Journal article
Nkumama IN. et al, (2024), Immunity
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Journal article
Mutemi DD. et al, (2024), Vaccines (Basel), 12
Integrating vaccines and monoclonal antibodies into malaria prevention.
Journal article
Taylor TE. and Osier F., (2024), Nat Med
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal article
Odera DO. et al, (2023), Sci Transl Med, 15
Malaria - Epidemiology, Treatment, and Prevention.
Journal article
Baden L. et al, (2023), N Engl J Med, 388
Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.
Journal article
Niaré K. et al, (2023), Front Immunol, 14
Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.
Journal article
Mwai K. et al, (2022), Malar J, 21
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Journal article
Fernandez N. et al, (2022), Front Immunol, 13
The effect of malaria on childhood anemia in a quasi-experimental study of 7,384 twins from 23 Sub-Saharan African countries.
Journal article
Starck T. et al, (2022), Front Public Health, 10